Personalized treatment in metastatic triple‐negative breast cancer: The outlook in 2020 von Azim, Hamdy A., Ghosn, Marwan, Oualla, Karima, Kassem, Loay

Volltext

Safety of pregnancy following breast cancer diagnosis: A meta-analysis of 14 studies von Azim, Hatem A, Santoro, Luigi, Pavlidis, Nicholas, Gelber, Shari, Kroman, Niels, Azim, Hamdy, Peccatori, Fedro A

Volltext

Predicting Brain Metastasis in Breast Cancer Patients: Stage Versus Biology von Azim, Hamdy A., Abdel-Malek, Raafat, Kassem, Loay

Volltext

Full population results from the core phase of CompLEEment-1, a phase 3b study of ribociclib plus letrozole as first-line therapy for advanced breast cancer in an expanded populati... von De Laurentiis, Michelino, Borstnar, Simona, Campone, Mario, Warner, Ellen, Bofill, Javier Salvador, Jacot, William, Dent, Susan, Martin, Miguel, Ring, Alistair, Cottu, Paul, Lu, Janice, Ciruelos, Eva, Azim, Hamdy A., Chatterjee, Sanjoy, Zhou, Katie, Wu, Jiwen, Menon-Singh, Lakshmi, Zamagni, Claudio

Volltext

Integrating PARP inhibitors into the management of breast cancer: where are we? von Azim, Hamdy A., Kassem, Loay, Azim Jr, Hatem

Volltext

Safety and efficacy of adjuvant subcutaneous trastuzumab in human epidermal growth factor receptor 2-positive early breast cancer: Final results of the SafeHER study von Gligorov, Joseph, Pivot, Xavier, Ataseven, Beyhan, De Laurentiis, Michelino, Jung, Kyung Hae, Manikhas, Alexey, Abdel Azim, Hamdy, Gupta, Kushagra, Alexandrou, Ari, Herraez-Baranda, Luis, Tosti, Nadia, Restuccia, Eleonora

Volltext

Treatment of HER2‐positive early breast cancer: How to best balance efficacy and toxicity? von Azim, Hamdy A., Lasheen, Shaimaa, Kassem, Loay

Volltext

Tailoring neoadjuvant systemic therapy in breast cancer: “The advent of a personalized approach”—The Breast‐Gynecological and Immuno‐Oncology International Cancer Conference (BGICC... von Elghazaly, Hesham, Azim, Hamdy A., Rugo, Hope S., Cameron, David, Swain, Sandra M., Curigliano, Giuseppe, Harbeck, Nadia, Tripathy, Debu, Arun, Banu, Aapro, Matti, Piccart, Martine, Cardoso, Fatima, Gligorov, Joseph, Elghazawy, Hagar, El Saghir, Nagi S., Penault‐Llorca, Frederique, Perez, Edith A., Poortmans, Philip, Abdelaziz, Hany, El‐Zawahry, Heba M., Kassem, Loay, Sabry, Mohamed, Viale, Giuseppe, Al‐Sukhun, Sana, Gado, Neven, Leung, Jessica W. T., Ezz Elarab, Lobna, Cardoso, Maria João, Abdel Karim, Khaled, Foheidi, Meteb, Elmaadawy, Merit M., Conte, Pierfranco, Selim, Ashraf S. M., Kandil, Alaa, Kamal, Rasha M., Paltuev, Ruslan M., Guarneri, Valentina, Abulkhair, Omalkhair, Zakaria, Omar, Golshan, Mehra, Orecchia, Roberto, ElMahdy, Manal, Abdel‐Aziz, Ahmed M., Eldin, Nermean Bahie

Volltext

Tailoring neo/adjuvant systemic therapy in breast cancer: “The advent of a personalized approach”—The Breast‐Gynecological and Immuno‐Oncology International Cancer Conference (BGIC... von Elghazaly, Hesham, Azim, Hamdy, Rugo, Hope, Cameron, David, Swain, Sandra, Curigliano, Giuseppe, Harbeck, Nadia, Tripathy, Debu, Arun, Banu, Aapro, Matti, Piccart, Martine, Cardoso, Fatima, Gligorov, Joseph, Elghazawy, Hagar, El Saghir, Nagi, Penault-Llorca, Frederique, Perez, Edith, Poortmans, Philip, Abdelaziz, Hany, El-Zawahry, Heba, Kassem, Loay, Sabry, Mohamed, Viale, Giuseppe, Al-Sukhun, Sana, Gado, Neven, Leung, Jessica, Ezz Elarab, Lobna, Cardoso, Maria João, Abdel Karim, Khaled, Foheidi, Meteb, Elmaadawy, Merit, Conte, Pierfranco, Selim, Ashraf, Kandil, Alaa, Kamal, Rasha, Paltuev, Ruslan, Guarneri, Valentina, Abulkhair, Omalkhair, Zakaria, Omar, Golshan, Mehra, Orecchia, Roberto, Elmahdy, Manal, Abdel-Aziz, Ahmed, Eldin, Nermean Bahie

Volltext

Adjuvant Subcutaneous Trastuzumab for HER2‐Positive Early Breast Cancer: Subgroup Analyses of Safety and Active Medical Conditions by Body Weight in the SafeHer Phase III Study von Jung, Kyung Hae, Ataseven, Beyhan, Verrill, Mark, Pivot, Xavier, De Laurentiis, Michelino, Al‐Sakaff, Nedal, Lauer, Sabine, Shing, Mona, Gligorov, Joseph, Azim, Hamdy A.

Volltext

Clinicopathologic Features of Breast Cancer in Egypt-Contemporary Profile and Future Needs: A Systematic Review and Meta-Analysis von Azim, Hamdy A, Elghazawy, Hagar, Ghazy, Ramy M, Abdelaziz, Ahmed H, Abdelsalam, Marwa, Elzorkany, Amira, Kassem, Loay

Volltext

Understanding the benefits and challenges of first‐line cyclin‐dependent kinases 4 and 6 inhibitors in advanced breast cancer among postmenopausal women von Azim, Hamdy A., Dawood, Shaheenah, El‐Saghir, Nagi, Kassem, Loay, Azim, Hatem A.

Volltext

The Landscape of BRCA Mutations among Egyptian Women with Breast Cancer von Azim, Hamdy A., Loutfy, Samah A., Azim, Hatem A., Kamal, Nermin S., Abdel Fattah, Nasra F., Elberry, Mostafa H., Abdelaziz, Mohamed R., Abdelsalam, Marwa, Aziz, Madonna, Shohdy, Kyrillus S., Kassem, Loay

Volltext

Correction to: Full population results from the core phase of CompLEEment-1, a phase 3b study of ribociclib plus letrozole as first-line therapy for advanced breast cancer in an ex... von De Laurentiis, Michelino, Borstnar, Simona, Campone, Mario, Warner, Ellen, Bofill, Javier Salvador, Jacot, William, Dent, Susan, Martin, Miguel, Ring, Alistair, Cottu, Paul, Lu, Janice, Ciruelos, Eva, Azim, Hamdy A., Chatterjee, Sanjoy, Zhou, Katie, Wu, Jiwen, Menon-Singh, Lakshmi, Zamagni, Claudio

Volltext

A randomized, phase 2 study comparing pemetrexed plus best supportive care versus best supportive care as maintenance therapy after first-line treatment with pemetrexed and cisplat... von Mubarak, Nabil, Gaafar, Rabab, Shehata, Samir, Hashem, Tarek, Abigeres, Dani, Azim, Hamdy A, El-Husseiny, Gamal, Al-Husaini, Hamed, Liu, Zhixin

Volltext

Breast cancer in Egypt, China and Chinese: statistics and beyond von Azim, Hamdy A, Ibrahim, Amal S

Volltext

Adjuvant ovarian function suppression and tamoxifen in premenopausal breast cancer patients: A meta-analysis von Azim, Hamdy A., Shohdy, Kyrillus S., Kaldas, David F., Kassem, Loay, Azim, Hatem A.

Volltext

Real-world treatment patterns and clinical outcomes in patients with stage III non-small cell lung cancer: results of KINDLE-Egypt cohort von Aboelhassan, Rasha, Sobeih, Mohamed Emam, El-Din, Mohamed Alm, Ghali, Ramy R., El-Din, Ibtessam Saad, Khorshid, Ola, Mokhtar, Mohsen, Rabea, Ahmed Magdy, Belal, Abdelaziz, Azim, Hamdy A., Abdullah, Mohamed, Elnahas, Tamer, Tawfik, Hesham, Abdelwahab, Sherif, Elsaid, Amr Abdelaziz, Hashem, Tarek, Mancy, Mohamed, Farag, Heba

Volltext

Durable Response of Androgen Receptor-Positive Male Breast Cancer to Goserelin von Abdel Azim, Hamdy, Kassem, Loay, Shohdy, Kyrillus Samaan, Eshaak, Boules, Anis, Shady Elia, Kamal, Nermine Shawky

Volltext

Analysis of PI3K/mTOR Pathway Biomarkers and Their Prognostic Value in Women with Hormone Receptor–Positive, HER2-Negative Early Breast Cancer von Azim, Hamdy A, Kassem, Loay, Treilleux, Isabelle, Wang, Qing, El Enein, Mona Abu, Anis, Shady E, Bachelot, Thomas

Volltext